ResearcherFujian Medical UniversityActive in the last 2 years
Hong-Yi Lin
Matched on ORCID iD 0000-0002-4623-0819; OpenAlex author ID A5111259342. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2024: 2 papers · 2025: 2 papers
Papers 4
- Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. Co-author DOI 10.1016/j.drup.2025.101240↗
- TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. Co-author DOI 10.1158/0008-5472.can-24-4784↗
- cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mTORC1 axis. Co-author DOI 10.1038/s41419-024-07138-y↗
- Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer. Co-author DOI 10.1186/s12943-024-02128-2↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cheng‐Yu Liao · 4 shared papers, 2024–2025 · strength 0.77
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Paper cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mT… DOI 10.1038/s41419-024-07138-y↗
- Zuwei Wang · 4 shared papers, 2024–2025 · strength 0.77
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Paper cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mT… DOI 10.1038/s41419-024-07138-y↗
- Chengke Xie · 4 shared papers, 2024–2025 · strength 0.77
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Paper cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mT… DOI 10.1038/s41419-024-07138-y↗
- Shi Chen · 4 shared papers, 2024–2025 · strength 0.77
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Paper cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mT… DOI 10.1038/s41419-024-07138-y↗
- Shun‐Cang Zhu · 3 shared papers, 2024–2025 · strength 0.59
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Paper cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mT… DOI 10.1038/s41419-024-07138-y↗
- Ge Li · 3 shared papers, 2024–2025 · strength 0.59
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Paper cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mT… DOI 10.1038/s41419-024-07138-y↗
- Yongding Wu · 3 shared papers, 2024–2025 · strength 0.59
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Paper Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer. DOI 10.1186/s12943-024-02128-2↗
- Haoxiang Zhang · 1 shared paper, 2025 · strength 0.20
- Yu Pan · 1 shared paper, 2025 · strength 0.20
- Yanling Chen · 1 shared paper, 2024 · strength 0.18
- Huixing Chen · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.